We are live on ! Find out more

53 hedge funds and large institutions have $73M invested in Exagen in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.78% more ownership

Funds ownership: 53.23%56.01% (+2.8%)

0% more funds holding

Funds holding: 5353 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

20% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 20

27% less capital invested

Capital invested by funds: $100M → $73M (-$27M)

Holders
53
Holders Change
Holders Change %
0%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
16
Reduced
20
Closed
7
Calls
$1.85M
Puts
Net Calls
+$1.85M
Net Calls Change
+$1.85M

XGN Hedge Fund Activity: Q1 2022 in Review

53 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q1 2022, worth a combined $73M — down 27% from $100M a quarter earlier.

Fund positioning in XGN was balanced in Q1 2022: 7 funds opened new positions, 7 closed out, 16 added to existing stakes and 20 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $2.26M. The largest seller was Maven Securities, exiting entirely with an estimated $610K sold.

  • 53 institutional investors held Exagen (XGN) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $73M of Exagen stock for Q1 2022, down 27% quarter-over-quarter.
  • 7 funds opened new Exagen positions in Q1 2022 and 7 closed out, a net change of 0 holders.
  • The largest Exagen buyer in Q1 2022 was Stonepine Capital Management, an estimated $2.26M added.
  • The largest Exagen seller in Q1 2022 was Maven Securities, an estimated $610K sold.

Based on aggregated 13F filings for Q1 2022.